Ichihara, Y.; Okawa, M.; Minegishi, M.; Oizumi, H.; Yamamoto, M.; Ohbuchi, K.; Miyamoto, Y.; Yamauchi, J.
Hypomyelinating Leukodystrophy 14 (HLD14)-Related UFC1 p.Arg23Gln Decreases Cell Morphogenesis: A Phenotype Reversable with Hesperetin. Medicines 2025, 12, 2.
https://doi.org/10.3390/medicines12010002
AMA Style
Ichihara Y, Okawa M, Minegishi M, Oizumi H, Yamamoto M, Ohbuchi K, Miyamoto Y, Yamauchi J.
Hypomyelinating Leukodystrophy 14 (HLD14)-Related UFC1 p.Arg23Gln Decreases Cell Morphogenesis: A Phenotype Reversable with Hesperetin. Medicines. 2025; 12(1):2.
https://doi.org/10.3390/medicines12010002
Chicago/Turabian Style
Ichihara, Yuri, Maho Okawa, Minori Minegishi, Hiroaki Oizumi, Masahiro Yamamoto, Katsuya Ohbuchi, Yuki Miyamoto, and Junji Yamauchi.
2025. "Hypomyelinating Leukodystrophy 14 (HLD14)-Related UFC1 p.Arg23Gln Decreases Cell Morphogenesis: A Phenotype Reversable with Hesperetin" Medicines 12, no. 1: 2.
https://doi.org/10.3390/medicines12010002
APA Style
Ichihara, Y., Okawa, M., Minegishi, M., Oizumi, H., Yamamoto, M., Ohbuchi, K., Miyamoto, Y., & Yamauchi, J.
(2025). Hypomyelinating Leukodystrophy 14 (HLD14)-Related UFC1 p.Arg23Gln Decreases Cell Morphogenesis: A Phenotype Reversable with Hesperetin. Medicines, 12(1), 2.
https://doi.org/10.3390/medicines12010002
